Key result
Chronic sitagliptin administration had context-dependent effects on blood pressure, increasing systolic BP by 10.3 mm Hg in spontaneously hypertensive rats but decreasing it by 7.7 mm Hg in metabolic syndrome rats.
Why the study?
Does sitagliptin alter arterial blood pressure in different rat models?
Does sitagliptin alter arterial blood pressure in different rat models?
The blood pressure effects of DPP4 inhibitors are context-dependent, potentially increasing BP in certain hypertensive states while decreasing it in metabolic syndrome models.
No takes yet. Share an insight, caveat, or question.
Sitagliptin BP effects in rat models should not change prescribing; leaves open context-specific DPP-4 actions in human hypertension subtypes.
Jackson et al. (2014) studied Hypertension and Metabolic Syndrome (Animal Models). Sitagliptin was evaluated on Arterial blood pressure (systolic, mean, and diastolic). Chronic sitagliptin administration had context-dependent effects on blood pressure, increasing systolic BP by 10.3 mm Hg in spontaneously hypertensive rats but decreasing it by 7.7 mm Hg in metabolic syndrome rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: